
Custom Surgical is a medtech company dedicated to becoming the global leader in digitalization and AI for diagnostic and surgical procedures in eyecare, empowering professionals with innovative imaging and data solutions. By delivering a universal, high-quality, affordable, and easy-to-use #MicroREC optical system, we enable doctors worldwide to record or take pictures of their microsurgeries or slit lamp diagnostics with their own smartphones in a simple way. #MicroRECApp is our second product and an application that allows doctors to improve their captures and recordings and manage their medical data anywhere and at any time. Get to know more about these and other products at: customsurgical.co

Custom Surgical is a medtech company dedicated to becoming the global leader in digitalization and AI for diagnostic and surgical procedures in eyecare, empowering professionals with innovative imaging and data solutions. By delivering a universal, high-quality, affordable, and easy-to-use #MicroREC optical system, we enable doctors worldwide to record or take pictures of their microsurgeries or slit lamp diagnostics with their own smartphones in a simple way. #MicroRECApp is our second product and an application that allows doctors to improve their captures and recordings and manage their medical data anywhere and at any time. Get to know more about these and other products at: customsurgical.co
Location: Munich, Germany
Product: MicroREC smartphone optical adapters and MicroREC mobile apps
Team size: Approximately 16 employees
Notable investor: Luminate NY (seed/accelerator)
Regulatory / quality: Claims FDA listing, EUDAMED registration, ISO 9001:2015
Digitization and AI-enabled imaging solutions for ophthalmic microscopy and slit-lamp diagnostics.
MedTech / Eyecare
Seed round closed on Oct 28, 2022; Crunchbase lists Luminate as investor. Company blog documents a $600,000 convertible note from Luminate NY tied to accelerator awards.
“Received seed-stage/accelerator investment from Luminate NY (including convertible-note funding tied to accelerator awards)”
| Company |
|---|